Innova Biosciences

Antibody labeling and bioconjugation kits.

Launch date

Apr 2002

Employees

Market cap

Enterprise valuation

€12m (Public information from Jun 2017)

Company register number 04415674

Over England (HQ)

http://innovabiosciences.com

https://twitter.com/innovabiosci https://www.facebook.com/InnovaBiosciences https://www.linkedin.com/company/1120724/

Revenues, earnings & profits over time

EUR	2016	2017	2018	2020	2021	2022
Revenues	2.9m	5.7m	<1m	-	-	-
% growth	-	94 %	(86 %)	-	-	-
EBITDA	<1m	1.3m	(<1m)	-	-	-
% EBITDA margin	25 %	23 %	(10 %)	-	-	-
Profit	<1m	1.2m	(<1m)	(<1m)	-	-
% profit margin	17 %	21 %	(12 %)	-	-	-

Date	Investors	Amount	Round
Jun 2017	Sygnis Pharma	€11.5m Valuation: €11.5m 3.9x EV/LTM Revenues 15.7x EV/LTM EBITDA	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.